CDCA3, a key regulator of the cell cycle, facilitates BLCA glycolysis by modulating the transcriptional expression of α-Enolase (ENO1), thereby enhancing BLCA progression. The gene discussed is CDCA3; the disease is bladder transitional cell carcinoma.